107 related articles for article (PubMed ID: 22951358)
21. Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing.
Hobbach HP; Schuster P
Z Kardiol; 2003 Mar; 92(3):213-8. PubMed ID: 12658467
[TBL] [Abstract][Full Text] [Related]
22. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial.
Bagai A; White JA; Lokhnygina Y; Giugliano RP; Van de Werf F; Montalescot G; Armstrong PW; Tricoci P; Gibson CM; Califf RM; Harrington RA; Newby LK
Am Heart J; 2013 Sep; 166(3):466-73. PubMed ID: 24016495
[TBL] [Abstract][Full Text] [Related]
23. Administration of intracoronary eptifibatide during ST-elevation myocardial infarction.
Pinto DS; Kirtane AJ; Ruocco NA; Deibele AJ; Shui A; Buros J; Murphy SA; Gibson CM
Am J Cardiol; 2005 Dec; 96(11):1494-7. PubMed ID: 16310428
[TBL] [Abstract][Full Text] [Related]
24. Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Mahmoudi M; Delhaye C; Wakabayashi K; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
J Interv Cardiol; 2011 Aug; 24(4):351-6. PubMed ID: 21426398
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction.
Nairooz R; Sardar P; Amin H; Swaminathan RV; Kim LK; Chatterjee S; Feldman DN
Am J Cardiol; 2014 Jul; 114(2):250-9. PubMed ID: 24890986
[TBL] [Abstract][Full Text] [Related]
26. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
[TBL] [Abstract][Full Text] [Related]
27. [Eptifibatide in patients with percutaneous coronary intervention in clinical practice. Results of a prospective registry].
Zeymer U; Zahn R; Siegler KE; Senges J
Herz; 2004 Nov; 29(7):651-5. PubMed ID: 15580318
[TBL] [Abstract][Full Text] [Related]
28. Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial.
Mrdovic I; Savic L; Krljanac G; Asanin M; Cvetinovic N; Brdar N; Stojanovic M; Djuricic N; Stankovic S; Marinkovic J; Perunicic J
J Interv Cardiol; 2013 Jun; 26(3):221-7. PubMed ID: 23373620
[TBL] [Abstract][Full Text] [Related]
29. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention.
Thiele H; Scholz M; Engelmann L; Storch WH; Hartmann A; Dimmel G; Pfeiffer D; Schuler G;
Am J Cardiol; 2006 Nov; 98(9):1132-9. PubMed ID: 17056313
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial).
Valencia R; Price MJ; Sawhney N; Lee SS; Wong GB; Gollapudi RR; Banares M; Schatz RA; Teirstein PS
Am J Cardiol; 2007 Oct; 100(7):1099-102. PubMed ID: 17884370
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
Gibson CM; Morrow DA; Murphy SA; Palabrica TM; Jennings LK; Stone PH; Lui HH; Bulle T; Lakkis N; Kovach R; Cohen DJ; Fish P; McCabe CH; Braunwald E;
J Am Coll Cardiol; 2006 Jun; 47(12):2364-73. PubMed ID: 16781360
[TBL] [Abstract][Full Text] [Related]
32. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
[TBL] [Abstract][Full Text] [Related]
33. Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction.
Gibson CM; Buros J; Ciaglo LN; Southard MC; Takao S; Harrigan C; Filopei J; Lew M; Marble SJ; Murphy SA; Cohen MG;
Am J Cardiol; 2007 Jul; 100(1):13-7. PubMed ID: 17599433
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
Lincoff AM; Roe M; Aylward P; Galla J; Rynkiewicz A; Guetta V; Zelizko M; Kleiman N; White H; McErlean E; Erlinge D; Laine M; Dos Santos Ferreira JM; Goodman S; Mehta S; Atar D; Suryapranata H; Jensen SE; Forster T; Fernandez-Ortiz A; Schoors D; Radke P; Belli G; Brennan D; Bell G; Krucoff M;
Eur Heart J; 2014 Oct; 35(37):2516-23. PubMed ID: 24796339
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study.
Ronner E; van Kesteren HA; Zijnen P; Altmann E; Molhoek PG; van der Wieken LR; Cuffie-Jackson CA; Neuhaus KL; Simoons ML
Eur Heart J; 2000 Sep; 21(18):1530-6. PubMed ID: 10973767
[TBL] [Abstract][Full Text] [Related]
36. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.
Armstrong PW;
Eur Heart J; 2006 Jul; 27(13):1530-8. PubMed ID: 16757491
[TBL] [Abstract][Full Text] [Related]
37. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S
Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719
[TBL] [Abstract][Full Text] [Related]
38. A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI.
Koul S; Andell P; Martinsson A; Smith JG; Scherstén F; Harnek J; Götberg M; Norström E; Björnsson S; Erlinge D
BMC Cardiovasc Disord; 2014 Dec; 14():189. PubMed ID: 25516485
[TBL] [Abstract][Full Text] [Related]
39. Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial.
Chang WC; Harrington RA; Simoons ML; Califf RM; Lincoff AM; Armstrong PW;
Eur Heart J; 2002 Jul; 23(14):1102-11. PubMed ID: 12090748
[TBL] [Abstract][Full Text] [Related]
40. Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy.
Gibson CM; Jennings LK; Murphy SA; Lorenz DP; Giugliano RP; Harrington RA; Cholera S; Krishnan R; Califf RM; Braunwald E;
Circulation; 2004 Aug; 110(6):679-84. PubMed ID: 15262838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
